Background
==========

Recent data suggested that heterozygous variants or defects in *NRXN1(Neurexin 1)*or *CNTNAP2 (contactin associated protein 2)*, both genes encoding neuronal cell adhesion molecules, represent susceptibility factors for a broad spectrum of neuropsychiatric disorders such as epilepsy, schizophrenia or autism spectrum disorder (ASD) with reduced penetrance and no or rather mild intellectual impairment \[[@B1]-[@B23]\]. In contrast, biallelic defects in either gene were reported to result in fully penetrant, severe neurodevelopmental disorders. Strauss et al. reported on a homozygous stop mutation in *CNTNAP2*in Old Order Amish children causing CDFE (Cortical Dysplasia - Focal Epilepsy) syndrome (MIM \#610042), characterized by cortical dysplasia and early onset, intractable focal epilepsy leading to language regression, and behavioral and mental deterioration \[[@B24],[@B25]\]. In a former study we reported on homozygous or compound heterozygous defects in *CNTNAP2*or *NRXN1*in four patients with intellectual disability and epilepsy \[[@B26]\], resembling Pitt-Hopkins syndrome (PTHS, MIM \#610954). A possible shared synaptic mechanism that was observed in *Drosophila*might contribute to the similar clinical phenotypes resulting from both heterozygous and recessive defects in human *CNTNAP2*or *NRXN1*\[[@B26]\].

To further delineate the clinical phenotype associated with potentially recessive defects in any of the two genes, we screened a group of patients with either severe intellectual disability resembling Pitt-Hopkins syndrome or the phenotypes caused by recessive *CNTNAP2*or *NRXN1*defects. Additionally, we performed mutational testing in patients found to harbor heterozygous deletions in either gene.

Methods
=======

Patients
--------

Our total cohort of patients comprised four different subsets: 1. our new Pitt-Hopkins syndrome-like (PTHSL) screening group, 2. parts of our old PTHSL screening group \[[@B26]\], 3. a group of patients with suspected recessive inheritance, and 4. patients with known heterozygous deletions in one of the two genes. 1. The new PTHSL screening group consisted of 90 patients who were initially referred with suspected Pitt-Hopkins syndrome for diagnostic testing of the underlying gene, *TCF4*, which encodes transcription factor 4. They all had severe intellectual disability and variable additional features reminiscent of the PTHS spectrum such as dysmorphic facial gestalt or breathing anomalies. Mutational testing of *TCF4*revealed normal results. In all of these 90 patients mutational screening of *NRXN1*and *CNTNAP2*was performed in the current study. Molecular Karyotyping was performed in 22 of them. This cohort does not overlap with the second subset, our old PTHSL screening group, which is a similar group of 179 patients, reported in a former study \[[@B26]\]. No published information on mutational screening of that group was included in the current study, but previously unpublished information on Molecular Karyotyping of 23 patients. 3. Nine patients with severe intellectual disability were referred to us specifically for *CNTNAP2/NRXN1*testing because of suspected autosomal-recessive inheritance and/or phenotypic overlap with the previously published patients \[[@B26]\]. 4. In eight patients copy number changes in either *NRXN1*or *CNTNAP2*were identified in other genetic clinics. These were referred to us for mutational screening of the second allele. These patients had variable degrees of intellectual disability and various other anomalies. An overview on tested patients is given in Table [1](#T1){ref-type="table"}. This study was approved by the ethics committee of the Medical Faculty, University of Erlangen-Nuremberg, and written consent was obtained from parents or guardians of the patients.

###### 

Overview on screened patients

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Patient samples used in this study            Sequencing of *NRXN1*number of patients                Sequencing of *CNTNAP2*number of patients              Molecular karyotyping number of patients
  --------------------------------------------- ------------------------------------------------------ ------------------------------------------------------ ------------------------------------------
  **1. new screening sample, n = 90**           90                                                     90, including C1-C4                                    22, including N1

  **2. old screening sample**\[[@B26]\]**,**\   published \[[@B26]\], results not used in this study   published \[[@B26]\], results not used in this study   23, not published before
  **n=179**                                                                                                                                                   

  **3. specific testing sample\***              9                                                      9                                                      

  **4. *NRXN1/CNTNAP2*deletion group\*\***      5, N2-N6                                               3, C5-C7                                               8, (details on arrays see Table 3)
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

\* Patients were referred to us specifically for *NRXN1/CNTNAP2*testing due to suspected autosomal recessive inheritance and/or phenotypic overlap with the previously published cases.

\*\* Patients were referred to us because of copy number changes in either *NRXN1*or *CNTNAP2*for screening of the respective second allele.

Molecular Karyotyping
---------------------

Molecular karyotyping was performed in 45 patients without *TCF4*mutation with an Affymetrix 6.0 SNP Array (Affymetrix, Santa Clara, CA), in accordance with the supplier\'s instructions. Copy-number data were analyzed with the Affymetrix Genotyping Console 3.0.2 software. In patient C3 molecular karyotyping was performed with an Affymetrix 500K array and data analysis was performed using the Affymetrix Genotyping Console 3.0.2 software.

The patients with heterozygous copy number variants (CNVs) referred for sequencing of the second allele, had been tested on different platforms. An overview on the array platforms, validation methods and segregation in the families is given in Tables [2](#T2){ref-type="table"} and [3](#T3){ref-type="table"}.

###### 

Molecular findings in *NRXN1*

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  *NRXN1*                                             Defect                                                                                                                                            Array Platform and\                                                                                                                              Validation of Array data                                  Inheritance                                                                                                              Carrier parent                                  Other non-polymorphic CNVs                                                    *NRXN1*\           *CNTNAP2*\
                                                                                                                                                                                                        details of *NRXN1/CNTNAP2*deletion                                                                                                                                                                                                                                                                                                                                                                                                                                sequen-cing        sequen-cing
  --------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------ --------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------ ----------------------------------------------- ----------------------------------------------------------------------------- ------------------ -------------
  **N1**                                              *NRXN1*deletion of exons 1-4                                                                                                                      Affymetrix 6.0 SNP Array\                                                                                                                        MLPA as reported previously \[[@B26]\]                    paternal                                                                                                                 healthy, normal intelligence                    none                                                                          no 2^nd^mutation   normal
                                                                                                                                                                                                        chr2:50.860.393-51.208.000\                                                                                                                                                                                                                                                                                                                                                                                                                                                          
                                                                                                                                                                                                        348 kb (230 array marker)                                                                                                                                                                                                                                                                                                                                                                                                                                                            

  **N2**                                              *NRXN1*deletion of exons 1-18                                                                                                                     Agilent 244K+customized array\                                                                                                                   customized Oligonucleotide array                          maternal                                                                                                                 learning disabilities and behavioral problems   none                                                                          no 2^nd^mutation   normal
                                                                                                                                                                                                        chr2:50.270.203-51.257.206\                                                                                                                                                                                                                                                                                                                                                                                                                                                          
                                                                                                                                                                                                        987 kb                                                                                                                                                                                                                                                                                                                                                                                                                                                                               

  **N3**                                              *NRXN1*deletion of exons 1-2                                                                                                                      Agilent 244A\                                                                                                                                    qPCR as reported previously \[[@B31]\]                    maternal                                                                                                                 healthy                                         21q22.3:44.534.530-44.820.473 pat dup\                                        no 2^nd^mutation   normal
                                                                                                                                                                                                        chr2:51.011.745-51.144.527\                                                                                                                                                                                                                                                                                                                                                         Xp22.33:0.000.001-2.710.316 mat dup                                                              
                                                                                                                                                                                                        133 kb                                                                                                                                                                                                                                                                                                                                                                                                                                                                               

  **N4**                                              *NRXN1*deletion of exons 1-4                                                                                                                      Agilent 244A\                                                                                                                                    FISH analysis with BAC clones RP11-67N9 and RP11-643L22   paternal                                                                                                                 healthy                                         15q26.1:88.028.337-88.072.545 mat del 16q12.1:50.773.658-51.135.179 mat dup   no 2^nd^mutation   normal
                                                                                                                                                                                                        chr2:50.800.974-51.286.171\                                                                                                                                                                                                                                                                                                                                                                                                                                                          
                                                                                                                                                                                                        425 kb                                                                                                                                                                                                                                                                                                                                                                                                                                                                               

  **N5**                                              *NRXN1*deletion of exons 3-4                                                                                                                      Agilent 244A\                                                                                                                                    qPCR as reported previously \[[@B31]\]                    paternal                                                                                                                 muscular problems & stroke; parents consang.    none                                                                          no 2^nd^mutation   normal
                                                                                                                                                                                                        chr2:50.861.527-51.090.563,\                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                                                        229 kb                                                                                                                                                                                                                                                                                                                                                                                                                                                                               

  **N6**                                              *NRXN1*deletion of exons 1-2                                                                                                                      Agilent 244A\                                                                                                                                    Agilent 244A of the parents                               de novo                                                                                                                                                                  none                                                                          no 2^nd^mutation   normal
                                                                                                                                                                                                        chr2:51.033.865-51.496.143\                                                                                                                                                                                                                                                                                                                                                                                                                                                          
                                                                                                                                                                                                        462 kb                                                                                                                                                                                                                                                                                                                                                                                                                                                                               

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  **published biallelic defect**\                     *NRXN1*deletion of exons 1-4 + p.S979X                                                                                                            Affymetrix 6.0 SNP Array\                                                                                                                                                                                  parents heterozygous carriers                                                                                            healthy                                                                                                                                          
  P3, Zweier et al. 2009\                                                                                                                                                                               113 kb                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
  **n = 1**\[[@B26]\]                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  **published heterozygous defects ass. with ASD**\   15x *NRXN1*deletion \[[@B5],[@B14],[@B16],[@B22]\], 2x NRXN1 gain \[[@B14]\], 1x balanced chromosomal rearrangement disrupting *NRXN1*\[[@B9]\]   12x Agilent 244K \[[@B5]\], 3x NimbleGen custom arrays \[[@B14]\], 1x Affymetrix 100 K Assay \[[@B16]\], 1x Affymetrix 10 K Assay \[[@B22]\],\                                                             6x de novo \[[@B5],[@B16],[@B22]\]; 5x mat \[[@B5],[@B14]\]; 4x pat \[[@B5],[@B9]\]; 3x not available \[[@B5],[@B14]\]                                                   1x duplication 14q24 \[[@B14]\]                                                                  
  **n = 18**\[[@B5],[@B9],[@B14],[@B16],[@B22]\]                                                                                                                                                        66 kb-5 Mb                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

mat, maternal; pat, paternal; dup, duplication; del, deletion; ass., associated; FISH, fluorescence in-situ hybridization; qPCR, quantitative Real-Time-PCR; non-polymorphic CNVs: CNVs that have not been reported in the Toronto Database of Genome Variants or have not been identified in one of our molecularly karyotyped healthy control indivuals

###### 

Molecular findings in *CNTNAP2*

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  *CNTNAP2*                                              Defect                                                                                                                                                                                       Array Platform and\                                                                       Validation of Array data                  Inheritance                                                                                                                                                           Carrier parent   Other non-polymorphic CNVs                                                        *NRXN1*\                     *CNTNAP2*\
                                                                                                                                                                                                                                                      details of *NRXN1/CNTNAP2*deletion                                                                                                                                                                                                                                                                                                                                                                           sequencing                   sequencing
  ------------------------------------------------------ -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------- ----------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------- --------------------------------------------------------------------------------- ---------------------------- -------------------------------
  **C1**                                                 *CNTNAP2*\                                                                                                                                                                                   Affymetrix 6.0 SNP Array,\                                                                                                          paternal                                                                                                                                                              healthy          chr9:9.337.920-10.207.671 mat dup\                                                normal                       no 2^nd^mutation; MLPA normal
                                                         c.1175_1176dup; p.D393RfsX51                                                                                                                                                                 normal results for *CNTNAP2*and *NRXN1*                                                                                                                                                                                                                                                                                    chr13:19.104.340-19.477.398 mat dup                                                                            

  **C2**                                                 *CNTNAP2*c.2153G\>A, p.W718X                                                                                                                                                                 Affymetrix 6.0 SNP Array,\                                                                                                          not known                                                                                                                                                             not known        none                                                                              normal                       no 2^nd^mutation; MLPA normal
                                                                                                                                                                                                                                                      normal results for *CNTNAP2*and *NRXN1*                                                                                                                                                                                                                                                                                                                                                                                                   

  **C3**                                                 *CNTNAP2*c.1083G\>A, splice site (p.V361V)                                                                                                                                                   Affymetrix 500 K SNP Array,\                                                                                                        paternal                                                                                                                                                              healthy          none                                                                              normal                       no 2^nd^mutation; MLPA normal
                                                                                                                                                                                                                                                      normal results for *CNTNAP2*and *NRXN1*                                                                                                                                                                                                                                                                                                                                                                                                   

  **C4**                                                 *CNTNAP2*c.1083G\>A, splice site (p.V361V)                                                                                                                                                   Illumina 317 K SNP Array,\                                                                                                          maternal                                                                                                                                                              healthy          **pathogenic frameshift mutation in MEF2C**(P7, Zweier et al. 2010) \[[@B28]\]    normal                       no 2^nd^mutation; MLPA normal
                                                                                                                                                                                                                                                      normal results for CNTNAP2 and *NRXN1*                                                                                                                                                                                                                                                                                                                                                                                                    

  **C5**                                                 *CNTNAP2*deletion of exons 2-3                                                                                                                                                               Affymetrix 6.0 SNP Array\                                                                 Affymetrix 6.0 SNP Array of the parents   maternal                                                                                                                                                              healthy          none                                                                              normal, one silent variant   no 2^nd^mutation
                                                                                                                                                                                                                                                      chr7:146.079.333-146.194.785\                                                                                                                                                                                                                                                                                                                                                                                                             
                                                                                                                                                                                                                                                      115 kb (69 array marker)                                                                                                                                                                                                                                                                                                                                                                                                                  

  **C6**                                                 *CNTNAP2*deletion of exons 3-4                                                                                                                                                               Illumina Human 660W-Quad\                                                                 qPCR as reported previously \[[@B32]\]    maternal                                                                                                                                                              healthy          none                                                                              normal                       no 2^nd^mutation
                                                                                                                                                                                                                                                      chr7:146.144.267-146.374.539\                                                                                                                                                                                                                                                                                                                                                                                                             
                                                                                                                                                                                                                                                      230 kb (53 array marker)                                                                                                                                                                                                                                                                                                                                                                                                                  

  **C7**                                                 *CNTNAP2*\                                                                                                                                                                                   Agilent 2 × 400 K\                                                                        customized Oligonucleotide array          de novo                                                                                                                                                               healthy          chr7:92.394.428-92.530.356 del chr7:93.464.449-94.430.690 del, both de novo\      normal                       no 2^nd^mutation
                                                         deletion of exons 21-24                                                                                                                                                                      chr7:147.702.165-148.378.711\                                                                                                                                                                                                                                                                                              conventional karyotyping: 46,XX,der(4)t(4;10)(q25;q24), der(7)t(4;7)(q25;q32),\                                
                                                                                                                                                                                                                                                      677 kb                                                                                                                                                                                                                                                                                                                     der(10)inv(10)(p13q24)(7;10)(q32;p13), de novo                                                                 

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                

  **published biallelic defects**\                       2x *CNTNAP2*deletion of exons 2-9, homozygous \[[@B26]\]; 1x *CNTNAP2*deletion of exons 5-8 + IVS10-1G\>T \[[@B26]\]; 10x *CNTNAP2*c.3709delG, homozygous \[[@B24],[@B25]\]                  2x Affymetrix 500 K/250 K Nsp SNP Array; 1x Affymetrix 6.0 SNP Array \[[@B26]\]; 10x no                                             parents heterozygous carriers                                                                                                                                                                                                                                                                         
  **n = 13**\[[@B24],[@B25]\]                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  **published heterozygous defects**\                    2x translocation disrupting *CNTNAP2*\[[@B12],[@B33]\], 1x inversion disrupting *CNTNAP2*\[[@B3]\], 5x *CNTNAP2*deletion \[[@B1],[@B7],[@B21]\], 4x missense variant in *CNTNAP2*\[[@B3]\]   3x BAC array \[[@B7]\], 1x NimbleGen custom array \[[@B21]\], 220 kb-11 Mb                                                          2x not reported \[[@B7]\], 4x inherited \[[@B3]\], 2x paternal \[[@B1],[@B21]\], 2x de novo \[[@B3],[@B7]\] 2x balanced in parent (translocation) \[[@B12],[@B33]\]                                                                                                                                   
  **n = 12**\[[@B1],[@B3],[@B7],[@B12],[@B21],[@B33]\]                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

mat, maternal; pat, paternal; dup, duplication; del, deletion; ass., associated; qPCR, quantitative Real-Time-PCR; non-polymorphic CNVs: CNVs that have not been reported in the Toronto Database of Genome Variants or have not been identified in one of our molecularly karyotyped healthy control indivuals

Mutational Screening and MLPA
-----------------------------

DNA samples of 107 patients were derived from peripheral blood, and if sample material was limited, whole genome amplification was performed using the Illustra GenomiPhi V2 DNA Amplification Kit (GE Healthcare, Little Chalfont, Buckinghamshire, United Kingdom) according to the manufacturer\'s instructions. All coding exons with exon-intron boundaries of *CNTNAP2*(NM_014141) and of isoforms alpha1, alpha2 and beta of *NRXN1*(NM_004801; NM_001135659; NM_138735) were screened for mutations by unidirectional direct sequencing (ABI BigDye Terminator Sequencing Kit v.3; AppliedBiosystems, Foster City, CA) with the use of an automated capillary sequencer (ABI 3730; Applied Biosystems). Mutations were confirmed with an independent PCR and bidirectional sequencing from original DNA. Primer pairs and conditions were used as previously described \[[@B26]\]. For splice site prediction, eight different online tools were used as indicated in Table [4](#T4){ref-type="table"}. Multiplex Ligation Dependent Probe Amplification (MLPA) for all coding exons of *CNTNAP2*was performed for patients C1-C4 as described previously \[[@B26]\].

###### 

Splice site prediction for splice donor variant c.1083G\>A

  -----------------------------------------------------------------------------------------
  Program                                    wild type score   mutant score
  ------------------------------------------ ----------------- ----------------------------
  NNSplice 0.9 \[[@B34]\]                    0.99              0.6

  HSF V2.4 \[[@B35]\]                        91.56             80.98

  MaxEntScan \[[@B36]\]                                        

  *Maximum Entropy Model*                    8.37              3.38

  *Maximum Dependence Decomposition Model*   11.88             9.78

  *First-order Markov Model*                 7.5               3.88

  *Weight Matrix Model*                      8.9               5.73

  Splice Site Score Calculation \[[@B37]\]   8.1               5.2

  Splice Site Analyzer-Tool \[[@B38]\]       83.27\            71.36\
                                             ΔG -7.1           ΔG -4

  Splice Predictor \[[@B39]\]                0.967             splice site not recognized

  NetGene2 \[[@B40]\]                        0.95              0.55

  SplicePort \[[@B41]\]                      1.06619           0.26169
  -----------------------------------------------------------------------------------------

Results
=======

Molecular Testing
-----------------

Mutational screening of *NRXN1*in 90 *TCF4*mutation negative patients and nine families with suspected recessive inheritance of severe intellectual disability did not reveal any point mutation, while in *CNTNAP2*the heterozygous mutation c.1083G\>A in the splice donor site of exon 7 was found in two patients (C3, C4). Eight prediction programs (Table [4](#T4){ref-type="table"}) showed diminished splice site recognition for this mutation, which is therefore predicted to result in an in-frame loss of exon 7. This possible splice site mutation was found in one of 384 control chromosomes. Furthermore, in patient C1 the heterozygous frameshift mutation p.D393RfsX51 in exon 8 and in patient C2 the heterozygous stop mutation p.W718X in exon 14 were identified. Due to their nature and location both truncating mutations are predicted to result in mRNA decay and loss of the affected allele. For patient C2 parents were not available, but all other mutations were shown to be inherited from a healthy parent. No defect on the second allele was identified in any of these patients by sequencing and subsequent MLPA-analysis of all coding exons. In 942 controls sequenced by Bakkaloglu et al. \[[@B3]\], no truncating mutation in *CNTNAP2*was found. No *CNTNAP2*deletion was found in 667 control individuals molecularly karyotyped \[[@B26]\].

Molecular karyotyping with an Affymetrix 6.0 SNP Array in 45 *TCF4*mutation negative patients revealed a heterozygous deletion within the *NRXN1*gene in one patient (N1). The father was shown to be healthy carrier, and no mutation on the second allele was found in this patient by sequencing of all coding exons.

In three patients with *CNTNAP2*deletions (C5-C7) and in five patients with *NRXN1*deletions (N2-N6) we could not identify any pathogenic mutation on the second allele by sequencing all coding exons. In patient N6 and in patient C7 the deletion within *NRXN1*or *CNTNAP2*was shown to be *de novo*. In all other families the deletion in *CNTNAP2*or *NRXN1*was also identified in one of the parents.

In all patients with a heterozygous defect in *CNTNAP2*we also screened *NRXN1*and vice versa, without observing any anomalies. An overview of localization of novel and published mutations and deletions is shown in Figure [1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}. Mutation and array data of novel patients are shown in Tables [2](#T2){ref-type="table"} and [3](#T3){ref-type="table"}.

![**Schematic drawing of *NRXN1*with localization of novel and published mutations and deletions**. Schematic drawing of genomic structure of alpha 1 isoform of *NRXN1*showing domain-coding exons and localization of mutations and deletions. Deletions found in our study are represented by black bars. Published biallelic aberrations are shown with black dotted lines, whereas heterozygous losses and gains are marked by grey solid and dashed lines, respectively. Abbreviations are as follows: SP, signal peptide; LamG, laminin-G domain; EGF, epidermal growth factor like domain; TM, transmembrane region; PDZBD, PDZ-domain binding site.](1471-2350-12-106-1){#F1}

![**Schematic drawing of *CNTNAP2*with localization of novel and published mutations and deletions**. Schematic drawing of genomic structure of *CNTNAP2*showing domain-coding exons and localization of mutations and deletions. Mutations and deletions found in our study are represented by black arrows and bars. Published biallelic aberrations are shown with black dotted lines, whereas heterozygous defects are shown in grey. Abbreviations are as follows: SP, signal peptide; DISC, discoidin-like domain; LamG, laminin-G domain; EGF, epidermal growth factor like domain; FIB, fibrinogen-like domain; TM, transmembrane region; PDZBD, PDZ-domain binding site.](1471-2350-12-106-2){#F2}

Clinical Findings
-----------------

Four of six patients with heterozygous CNVs in *NRXN1*were severely intellectually disabled (N1-N4). Three had epilepsy and one episodic hyperbreathing. Patients N5 and N6 were only mildly intellectually disabled and N5 additionally had various malformations like choanal atresia, anal atresia, and skeletal anomalies. All patients had absent or impaired language abilities, while motor development was normal or only mildly delayed in four of them. The deletion in patient N6 was shown to be *de novo*, in all other families one parent was shown to be carrier of the deletion. The mother of N2 was reported to have had learning difficulties, all others were reported to be healthy and of normal intelligence. However, detailed neuropsychiatric testing was not performed. Summarized clinical details of the patients are shown in Table [5](#T5){ref-type="table"}.

###### 

Clinical findings associated with defects in *NRXN1*

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  *NRXN1*                                             Sex & Age   ID                                                                                                                                                        Speech                                                          Age of Walking                    Seizures\            Birth parameters\     Weight\        Behavioral anomalies/\                                              Facial dysmorphisms                                                                                          Other findings
                                                                                                                                                                                                                                                                                                                              age of onset         Weight, Heigth, OFC   Height\        Stereotypies                                                                                                                                                                     
                                                                                                                                                                                                                                                                                                                                                                         OFC                                                                                                                                                                                             
  --------------------------------------------------- ----------- --------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------- --------------------------------- -------------------- --------------------- -------------- ------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------ ----------------------------------------------------------------------------------------------------------------------------------------------------------------
  **N1**                                              m, 14y      Severe                                                                                                                                                    at 3y: max. 10 single words, lost this function                 14mo                              yes                  2900 g\               P25-P50\       yes,\                                                               large mouth, widely spaced teeth, upslanting palpebral fissures, strabism                                    hyperbreathing
                                                                                                                                                                                                                                                                                                                                                   52 cm\                P25-P50\       puts objects in his mouth                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                   34 cm                 P90                                                                                                                                                                                             

  **N2**                                              m, 6y       Severe                                                                                                                                                    at 24mo: single words and two word combinations,\               16mo                              none                 3740 g\               Normal\        none                                                                macrocephaly (also maternal and paternal), large mouth, retrogenia                                           muscular hypotonia, MRI: wide ventricles
                                                                                                                                                                                                                            receptive better than expressive                                                                                       51 cm\                \<P3\                                                                                                                                                                                           
                                                                                                                                                                                                                                                                                                                                                   38.5 cm               \>P95                                                                                                                                                                                           

  **N3**                                              m, 3y 4mo   Severe                                                                                                                                                    no active speech                                                14mo                              none                 3350 g\               P50-P75\       yes                                                                 none                                                                                                         none
                                                                                                                                                                                                                                                                                                                                                   52 cm\                P75-P90\                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                   35 cm                 P50-P75                                                                                                                                                                                         

  **N4**                                              f, 16y      Severe                                                                                                                                                    none                                                            no                                grand mal\           3530 g\               P10-P25\       yes,\                                                               broad nasal tip, pointed chin                                                                                drooling, friendly
                                                                                                                                                                                                                                                                                                                              4y                   51 cm\                P25-P50\       hand licking                                                                                                                                                                     
                                                                                                                                                                                                                                                                                                                                                   33 cm                 \<P5                                                                                                                                                                                            

  **N5**                                              m, 21y      Mild                                                                                                                                                      impaired                                                        not known                         grand mal,\          3300 g\               P3-P10\        none                                                                mild facial asymmetry, small ears, broad nose, broad mouth, bushy eye brows, high arched palate, cleft lip   pectus excavatum, single transverse palmar crease, choanal atresia, anal atresia, thick finger joints, ureter stenosis, delayed bone age, spondyloptosis L5/S1
                                                                                                                                                                                                                                                                                                                              6y (until age 11y)   51 cm\                \<P3\                                                                                                                                                                                           
                                                                                                                                                                                                                                                                                                                                                   33 cm                 P50                                                                                                                                                                                             

  **N6**                                              f, 6y 3mo   Mild                                                                                                                                                      2 y: first words, speech delay mainly affecting active speech   21mo                              none                 2820 g\               P10-P25\       none                                                                protruding ears                                                                                              muscular hypotonia (improved), scapulae alatae, mild lordosis, tendency to diarrhea
                                                                                                                                                                                                                                                                                                                                                   50 cm\                P3\                                                                                                                                                                                             
                                                                                                                                                                                                                                                                                                                                                   35 cm                 P10-P25                                                                                                                                                                                         

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

  **published biallelic defect**\                     f, 18y      Severe                                                                                                                                                    none                                                            2y                                none                 3450 g\               P50-P75\       yes, hypermotoric behavior                                          broad mouth, strabism, protruding tongue                                                                     excessive drooling, developmental regression, abnormal sleep-wake-cycles, decreased deep-tendon reflexes upper extremities, hyperbreathing
  P3, Zweier et al. 2009\                                                                                                                                                                                                                                                                                                                          normal                P50-P75\                                                                                                                                                                                        
  **N = 1**\[[@B26]\]                                                                                                                                                                                                                                                                                                                                                    P25                                                                                                                                                                                             

  **published heterozygous defects ass. with ASD**\               7x normal \[[@B5]\], 3x learning problems \[[@B5],[@B14]\] 2x dev. Delay \[[@B5],[@B22]\], 3x mild ID \[[@B9],[@B14],[@B16]\], 2x moderate ID \[[@B5]\]   14x language delay \[[@B5],[@B14],[@B16],[@B22]\]               5x motor delay \[[@B5],[@B16]\]   1x yes \[[@B5]\]     not reported          not reported   11x ASD or Asperger syndrome \[[@B5],[@B9],[@B14],[@B16],[@B22]\]   11x mild dysmorphic features \[[@B5],[@B14],[@B16]\]                                                         1x VACTERL association \[[@B5]\], 1x mild skeletal anomalies \[[@B16]\], 4x hypotonia, 2x ventricular septum defect, 3x hemangioma \[[@B5]\]
  **N = 18**\[[@B5],[@B9],[@B14],[@B16],[@B22]\]                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

TOF, tetralogy of Fallot; f, female; m, male; y, year; mo, month; ASD, autism spectrum disorder; published reports on CNTNAP2 and NRXN1: only papers containing clinical data are cited; ass., associated; P, centile; ass., associated

All seven patients with heterozygous defects in *CNTNAP2*in this study showed severe to profound intellectual disability. Speech was lacking in four patients (C1, C4-C6) and reported to be simple in C7. Patient C3 lost her speech ability at age 2.5 years. Motor impairment was also severe with no walking abilities in three patients (C4-C6), patient C7 started to walk at the age of 15 months, and patients C1 and C3 lost this function at age 2.5 - 3 years. Five patients had seizures. As far as data were available, epilepsy was of early onset and difficult to treat. At least in two of the patients episodes of hyperbreathing were reported. Congenital anomalies and malformations such as tetralogy of Fallot, pyloric stenosis, and variable other anomalies or septo-optical dysplasia were reported in patients C1 and C5, respectively. In the parents shown to be carriers, no neuropsychiatric anomalies were reported. However, detailed neuropsychiatric testing was not performed.

Summarized clinical details of the patients are shown in Table [6](#T6){ref-type="table"}.

###### 

Clinical findings associated with defects in *CNTNAP2*

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  *CNTNAP2*                                              Sex & Age                             ID                                                                                                                                 Speech                                                                                                                      Age of Walking                                                           Seizures\                                                                                   Birth parameters\     Weight\         Behavioral anomalies/\                                                                 Facial dysmorphisms                                                                                                 Other findings
                                                                                                                                                                                                                                                                                                                                                                                                                                       age of onset                                                                                Weight, Heigth, OFC   Height\         Stereotypies                                                                                                                                                                                               
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         OFC                                                                                                                                                                                                                        
  ------------------------------------------------------ ------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------ ------------------------------------------------------------------------------------------- --------------------- --------------- -------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **C1**                                                 f, 8y                                 Severe                                                                                                                             none                                                                                                                        2y with aid, lost this function (3y)                                     yes, resist. to treatment                                                                   2430 g\               \<P3\           hand movements                                                                         synophrys, long eyelashes, prominent columella, short philtrum, arched palate, widely spaced teeth, prominent jaw   happy, affectionate, TOF, pyloric stenosis, vesicoureteric reflux, agenesis of labia minora, hirsutism, tapering fingers
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   45 cm\                \<P3\                                                                                                                                                                                                                      
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   not reported          \<P3                                                                                                                                                                                                                       

  **C2**                                                 m, 18y                                Severe                                                                                                                             ?                                                                                                                           ?                                                                        complex,\                                                                                   ?                     ?               ?                                                                                                                                                                                                          hyperbreathing, apnoe episodes
                                                                                                                                                                                                                                                                                                                                                                                                                                       early onset                                                                                                                                                                                                                                                                                                                                  

  **C3**                                                 f, 11y                                Severe                                                                                                                             few words, lost this function                                                                                               2,5y, lost this function                                                 3y                                                                                          3510 g                P10\            yes                                                                                    broad mouth, protruding tongue                                                                                      develop. regression from 15 m, swallowing problems, nocturnal laughing, scoliosis, spastic tetraparesis, hyperreflexia, constipation, hyperbreathing
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         \<P3\                                                                                                                                                                                                                      
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         P10                                                                                                                                                                                                                        

  **C4**\                                                f, 7y                                 Profound                                                                                                                           none                                                                                                                        no                                                                       3-6mo                                                                                       3400 g                P5\             yes                                                                                    broad forehead, prominent ear lobes, widely spaced teeth, tented upper lip                                          exotropia, heterochromasia, high pain threshold, cold feet, sleeping problems, joint hyperlaxity
  Zweier et al., 2010 \[[@B28]\]                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         \<P2\                                                                                                                                                                                                                      
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         P50                                                                                                                                                                                                                        

  **C5**                                                 f, 2y 8mo                             Profound                                                                                                                           none                                                                                                                        no,\                                                                     none                                                                                        4030 g\               P75\                                                                                                   high arched palate, upslanting palpebral fissures, small teeth, prominent forehead                                  septo-optical dysplasia, MRI: agenesis of septum pellucidum
                                                                                                                                                                                                                                                                                                                                                              no crawling                                                                                                                                                          53 cm\                P25-50                                                                                                                                                                                                                     
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   38 cm                                                                                                                                                                                                                                            

  **C6**                                                 f, 8y                                 Profound                                                                                                                           none                                                                                                                        no                                                                       yes, resist. to treatment                                                                   1160 g\               \<P3\                                                                                                  mild synophrys, low set, large ears, fleshy ear lobes, thin upper lip, low frontal hairline                         birth at 29^th^week of gestation, blindness, hydrocephalus, ductus arteriosus, syndactyly toes 2-3, hypotonia, spasticity of legs, obstipation, liquid uptake by PEG tube
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   35 cm\                \<P3\                                                                                                                                                                                                                      
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   28 cm                 \<P5                                                                                                                                                                                                                       

  **C7**                                                 f, 8y                                 moderate to severe                                                                                                                 simple                                                                                                                      15mo                                                                     none                                                                                        3860 g\               P25-P50\        suspected in infancy                                                                   epicanthal folds, tented upper lip, short columella, bulbous nose                                                   overfriendliness, pubertas praecox, delayed bone age, retentive memory, excessive empathy, autoagressive behavior, flat feet
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   54 cm\                P50\                                                                                                                                                                                                                       
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   34 cm                 \<P5                                                                                                                                                                                                                       

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    

  **published biallelic defects**\                       2x f, 1x m, 10x not reported, 1-20y   Severe                                                                                                                             2x no, 1x single words \[[@B26]\], 10x yes, but regression \[[@B24],[@B25]\]                                                2x normal, 1x not known \[[@B26]\], 10x 16mo-30mo \[[@B24],[@B25]\]      13x yes,\                                                                                   not reported          \<P3-normal\    8x yes \[[@B24],[@B26]\], 1x tooth grinding and repetitive hand movements \[[@B26]\]   2x wide mouth and thick lips \[[@B26]\]                                                                             1x dry skin, 1x regression, 1x cerebellar hypoplasia,\
  **N = 13**\[[@B24],[@B25]\]                                                                                                                                                                                                                                                                                                                                                                                                          4mo-30mo                                                                                                          not reported\                                                                                                                                                                                                              3x hyperbreathing \[[@B26]\], 10x developmental regression with onset of seizures, 9x decreased deep tendon reflexes \[[@B24],[@B25]\], 4x MRI: cortical dysplasia \[[@B24]\], 1x MRI: leukomalacia, 1x hepatosplenomegaly \[[@B25]\]
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         \<P3-P99                                                                                                                                                                                                                   

  **published heterozygous**\                                                                  6x not reported \[[@B1],[@B3],[@B21]\], 1x normal \[[@B7]\], 2x mild-moderate \[[@B3],[@B7]\], 3x severe \[[@B7],[@B12],[@B33]\]   6x not reported \[[@B1],[@B3],[@B21]\], 1x normal \[[@B7]\], 3x speech impairment \[[@B7],[@B12]\] 2x no \[[@B7],[@B33]\]   11x not reported \[[@B1],[@B3],[@B7],[@B12],[@B21]\], 1x no \[[@B33]\]   5x not reported \[[@B1],[@B3]\], 2x no \[[@B12],[@B33]\], 5x yes \[[@B3],[@B7],[@B21]\],\   not reported          not reported    8x yes \[[@B1],[@B3],[@B7]\]                                                           not reported                                                                                                        1x multiple congenital malformations \[[@B33]\], 1x Gilles de la Tourette syndrome \[[@B12]\], 3x Schizophrenia \[[@B7]\]
  **defects**\                                                                                                                                                                                                                                                                                                                                                                                                                         0y-34y                                                                                                                                                                                                                                                                                                                                       
  **N = 12**\[[@B1],[@B3],[@B7],[@B12],[@B21],[@B33]\]                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

TOF, tetralogy of Fallot; f, female; m, male; y, year; mo, month; ASD, autism spectrum disorder; published reports on CNTNAP2 and NRXN1: only papers containing clinical data are cited; ass., associated; P, centile; ass., associated

Discussion
==========

*NRXN1*. While the majority of the novel patients had severe intellectual disability, only two of the patients, N5 and N6, with heterozygous deletions in *NRXN1*had mild intellectual disability as reported before for this kind of defects \[[@B5],[@B9],[@B11],[@B14],[@B16]\]. Additionally, patient N5 had various congenital malformations and anomalies. Interestingly, one recently published patient with a *NRXN1*defect and no significant intellectual impairment was reported with similar malformations resembling the VACTERL spectrum \[[@B5]\]. Mild skeletal anomalies were also reported in the patient published by Zahir et al. \[[@B16]\]. A larger number of patients and therefore further delineation of the phenotype will probably clarify a possible relation of such malformations to *NRXN1*defects. All other four patients with heterozygous *NRXN1*deletions were severely intellectually disabled without specific further anomalies. Their phenotype resembled the patient reported with a compound heterozygous defect in this gene \[[@B26]\]. Except for patient N4, speech impairment was severe compared to a rather mild motor delay. Because of the severe phenotype in the patients in contrast to the normal or only mildly impaired intellectual function in the respective carrier parent, a defect of the second allele was suspected in the patients, but not found.

*CNTNAP2*. Most of the clinical aspects and the severity of intellectual disability in the herewith reported patients with heterozygous *CNTNAP2*defects resembled those observed in patients with biallelic defects in *CNTNAP2*reported before (Table [6](#T6){ref-type="table"}). Two of the patients (C1, C3) showed language and motor regression correlating with onset of epilepsy. All others showed lacking or severely impaired speech development. However, in contrast to the published patients with recessive defects and normal or only mildly delayed motor development \[[@B24],[@B26]\], all but one patients in this study also showed severe motor retardation. We could not identify a defect on the second allele in any of the novel patients. In most of the families the defect was inherited from a healthy parent. Despite a significantly higher frequency (p \< 0.01, Fisher\'s exact test) of two truncating mutations in our cohort of 99 severely to profoundly intellectually disabled patients compared to no truncating mutation in 942 normal controls \[[@B3]\] definite proof that the respective mutation is fully responsible for the phenotype is so far lacking. This also applies to the other identified defects in *CNTNAP2*or *NRXN1*.

Congenital malformations as described in patients C1 or C5 (Table [6](#T6){ref-type="table"}) have not yet been reported in any other patient with a *CNTNAP2*defect. Furthermore, the fact that the expression of the gene is restricted to the nervous system \[[@B27]\] does not explain these anomalies. Therefore, another genetic cause for these malformations might exist. Thus it is difficult to define if the intellectual disability is associated with the *CNTNAP2*mutation at all in these patients. Other factors like premature complicated birth in patient C6 might contribute to impaired intellectual function. C3 and C4 carried the same splice site mutation and both showed a similar phenotype with severe intellectual disability and seizures, C3 also with breathing anomalies. In a parallel research project, a mutation in the *MEF2C*gene was identified in patient C4 and shown to be capable of causing all of her symptoms \[[@B28]\]. Therefore, it remains unclear if this splice mutation has a pathogenic effect at all, or only a mild effect that is masked by the severe consequences of the *MEF2C*mutation. The fact that this variant is supposed to lead to an in-frame loss of a single exon with a possibly milder effect than more deleterious defects supports the idea of no or only minor relevance of this splice mutation. Regarding the relatively high frequency of the splice site mutation in two families and one control, a founder effect might be considered, however, common regional background in these persons is not obvious.

Expanding the observations from previous studies we now found that heterozygous defects in *CNTNAP2*or *NRXN1*can also be seen in association with severe intellectual disability. Possible explanations might be: 1. No pathogenic relevance of the identified defect. This might indeed be the case for those patients with a \"mild mutation\" such as the splice-site mutation in *CNTNAP2*, or for patients with an atypical phenotype or congenital malformations. In those, the true causative defect might not be detected yet. However, published data and our data together still support a pathogenic role for both genes in neurodevelopmental disorders. 2. Inability to identify a defect on the second allele in spite of extensive screening for mutations and/or deletions. However, mutations in regulatory elements or in additional alternative isoforms cannot be excluded in any case. 3. A larger phenotypic variability associated with heterozygous defects in each gene. The finding of homozygous or compound heterozygous defects in previous patients with severe phenotypes \[[@B24]-[@B26]\] indicates the existence of second hits or additional major contributors. These might not necessarily be affecting the same gene. Only recently, a two-hit model for severe developmental delay in patients with a recurrent 16p12.1 microdeletion was postulated \[[@B29]\]. This might also be the case for microdeletions or even point mutations within a single gene as already reported for digenic inheritance in specific ciliopathies like Bardet-Biedl syndrome \[[@B30]\]. In four of our patients additional *de novo*or parentally inherited CNVs were identified (see Tables [2](#T2){ref-type="table"} and [3](#T3){ref-type="table"}), however, the significance of these CNVs is unclear. The possible functional synaptic link between *CNTNAP2*and *NRXN1*\[[@B24]-[@B26]\] prompted us to screen *CNTNAP2*in patients with *NRXN1*defects and vice versa, however, without any mutation detected.

Conclusion
==========

We found heterozygous defects in *CNTNAP2*and *NRXN1*in patients with severe intellectual disability, therefore expanding the clinical spectrum associated with monoallelic defects in either gene. This large variability implicates difficulties for genetic counseling in such families. To explain the larger phenotypic variability and severity in some patients we suggest a contribution of major additional genetic factors. To identify these possible contributors and modifiers will be a great challenge for the near future.
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